Breaking News Instant updates and real-time market news.

TSRO

TESARO

$147.24

-1.61 (-1.08%)

12:46
01/11/17
01/11
12:46
01/11/17
12:46

TESARO call volume above normal and directionally bullish

Bullish option flow detected in TESARO with 1,264 calls trading, 1.8x expected, and implied vol increasing almost 2 points to 54.80%. Jan-17 155 calls and Jan-18 110 puts are the most active options, with total volume in those strikes near 540 contracts. The Put/Call Ratio is 0.51. Earnings are expected on February 23rd.

  • 11

    Jan

  • 30

    Jun

TSRO TESARO
$147.24

-1.61 (-1.08%)

12/27/16
FBRC
12/27/16
NO CHANGE
Target $151
FBRC
Outperform
FBR Capital ups TESARO price target to $151
FBR Capital analyst Ed White raised his price target for TESARO to $151 from $133 and keeps the Outperform rating on the shares. The oncology-focused biopharmaceutical company closed Friday up $7.27 to $139.86. TESARO recently announced that the FDA has granted Priority Review for niraparib with a June 30, 2017 action date, White tells investors in a research note. He believes niraparib could be a potential blockbuster PARP inhibitor. Meanwhile, the launch of Varubi continues to "ramp up," with sequential quarter-over-quarter unit growth of 14%, the analyst writes. White says the drug achieved a 28% share of the oral NK-1 market in the U.S. in September.
01/04/17
GABE
01/04/17
NO CHANGE
GABE
Gabelli sees Incyte as more likely target following Gilead hire
Gilead (GILD) is more likely to buy Incyte (INCY) after naming Alessandro Riva to head its Hematology and Oncology Therapeutic unit, Gabelli analyst Jing He tells investors in a research note. Dr. Riva is a Novartis (NVS) veteran while Incyte is led by a team of Novartis veterans and has collaborated with Novartis Oncology on its key drug, Jakafi, the analyst points out. He believes Incyte is "big enough to move the needle" and bring long term growth to Gilead. The analyst lists Seattle Genetics (SGEN) and TESARO (TSRO) as other potential targets for the biotech giant. He believes Incyte is the "best fit."
01/09/17
LEER
01/09/17
NO CHANGE
Target $152
LEER
Outperform
TESARO price target raised to $152 from $115 at Leerink
Leerink analyst Seamus Fernandez raised his price target for TESARO to $152 from $115 to fully incorporate his high expectations for a broad label and reflect niraparib's transformation to a commercial stage asset. The analyst notes that the "strong data" from niraparib's NOVA trial, along with the lack of an expected FDA panel, should result in a broad label in the second-line or greater ovarian cancer maintenance setting, while ongoing niraparib trials in breast cancer and front-line ovarian cancer maintenance and the company's IO platform should be additional potential drivers of upside for the stock. Fernandez sees TESARO as an "attractive takeout target," and reiterates an Outperform rating on the shares.
01/10/17
LEER
01/10/17
NO CHANGE
LEER
Outperform
ARIAD acquisition supports potential takeout premium for TESARO, says Leerink
Leerink analyst Seamus Fernandez says the acquisition of ARIAD (ARIA) by Takeda (TKPYY) for $24 per share appears to be relatively in-line with other commercial stage acquisitions, and supports a potential acquisition price for TESARO (TSRO) of greater than $170 per share based on consensus forecasts. While TESARO remains well positioned to grow independently, the analyst believes a validated PARP inhibitor like niraparib could offer a durable and strategically important product opportunity for multiple suitors. He reiterates an Outperform rating on TESARO's shares.

TODAY'S FREE FLY STORIES

RMR

RMR Group

$42.90

0.65 (1.54%)

09:44
01/23/17
01/23
09:44
01/23/17
09:44
Conference/Events
RMR Group management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

HAL

Halliburton

09:44
01/23/17
01/23
09:44
01/23/17
09:44
Hot Stocks
Breaking Hot Stocks news story on Halliburton »

Halliburton says sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

JPM

JPMorgan

09:43
01/23/17
01/23
09:43
01/23/17
09:43
Conference/Events
JPMorgan management to meet with Evercore ISI »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 16

    Feb

  • 28

    Feb

  • 14

    Jul

  • 12

    Oct

ASM

Avino Silver & Gold Mines

09:42
01/23/17
01/23
09:42
01/23/17
09:42
Hot Stocks
Breaking Hot Stocks news story on Avino Silver & Gold Mines »

Avino Silver & Gold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:42
01/23/17
01/23
09:42
01/23/17
09:42
General news
Stocks little changed in early trade ahead of busy week for earnings »

Stock futures drifted…

CNCO

Cencosud

09:41
01/23/17
01/23
09:41
01/23/17
09:41
Upgrade
Cencosud rating change  »

Cencosud upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

, HAL

Halliburton

09:41
01/23/17
01/23
09:41
01/23/17
09:41
Options
Unusually active option classes on open January 23rd »

Unusual total active…

MCD

McDonald's

HAL

Halliburton

DXJ

WisdomTree Japan Hedged Equity Fund

STX

Seagate

$36.47

0.13 (0.36%)

MET

MetLife

PBR

Petrobras

TWTR

Twitter

BABA

Alibaba

AKS

AK Steel

INTC

Intel

$36.94

0.37 (1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 26

    Jan

  • 02

    Feb

  • 09

    Feb

  • 21

    Feb

  • 28

    Feb

  • 05

    Mar

  • 13

    Jun

FNSR

Finisar

$30.00

-0.89 (-2.88%)

09:39
01/23/17
01/23
09:39
01/23/17
09:39
Recommendations
Finisar analyst commentary  »

Finisar shares defended…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Mar

TRGP

Targa Resources

09:37
01/23/17
01/23
09:37
01/23/17
09:37
Syndicate
Targa Resources 8M share Spot Secondary priced at $57.65 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

HAL

Halliburton

09:37
01/23/17
01/23
09:37
01/23/17
09:37
Hot Stocks
Breaking Hot Stocks news story on Halliburton »

Halliburton says sees Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

QCOM

Qualcomm

$62.88

-1.56 (-2.42%)

09:36
01/23/17
01/23
09:36
01/23/17
09:36
Technical Analysis
Qualcomm accelerates to the downside, breaks intraday support »

Shares were last at $57,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 07

    Feb

  • 13

    Mar

UA

Under Armour

, DOW

Dow Chemical

09:35
01/23/17
01/23
09:35
01/23/17
09:35
Hot Stocks
President Trump speaks of 'substantial' border tax »

President Trump, while…

UA

Under Armour

DOW

Dow Chemical

TSLA

Tesla

$244.73

0.97 (0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

  • 31

    Jan

  • 02

    Feb

AMZN

Amazon.com

$808.33

-0.71 (-0.09%)

09:35
01/23/17
01/23
09:35
01/23/17
09:35
Periodicals
Amazon considers paid search on Alexa, Business Insider reports »

Amazon is considering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

  • 28

    Feb

HAL

Halliburton

09:35
01/23/17
01/23
09:35
01/23/17
09:35
Hot Stocks
Halliburton says had Q4 costs from more head count reductions »

Says cut more jobs in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

09:35
01/23/17
01/23
09:35
01/23/17
09:35
General news
Trump underscored his pro-business bona fides with CEOs »

Trump underscored his…

FNSR

Finisar

$30.00

-0.89 (-2.88%)

09:33
01/23/17
01/23
09:33
01/23/17
09:33
Technical Analysis
Finisar breaks down sharply, bearish pattern now active »

The stock is down over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Mar

CPN

Calpine

09:32
01/23/17
01/23
09:32
01/23/17
09:32
Downgrade
Calpine rating change  »

Calpine downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

  • 28

    Feb

NRG

NRG Energy

09:32
01/23/17
01/23
09:32
01/23/17
09:32
Upgrade
NRG Energy rating change  »

NRG Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

PEBO

Peoples Bancorp

$31.43

0.5 (1.62%)

09:31
01/23/17
01/23
09:31
01/23/17
09:31
Hot Stocks
Peoples Bancorp Chief Commercial Banking Officer Daniel McGill resigns »

Peoples Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

FNSR

Finisar

$30.00

-0.89 (-2.88%)

, OCLR

Oclaro

$9.37

-0.11 (-1.16%)

09:30
01/23/17
01/23
09:30
01/23/17
09:30
Hot Stocks
Finisar lower after Rosenblatt uncovers Huawei disqualification »

Rosenblatt analyst Jun…

FNSR

Finisar

$30.00

-0.89 (-2.88%)

OCLR

Oclaro

$9.37

-0.11 (-1.16%)

LITE

Lumentum

$35.15

0.05 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 07

    Feb

  • 22

    Feb

  • 16

    Mar

09:30
01/23/17
01/23
09:30
01/23/17
09:30
General news
Treasury Action: Treasury supply is heavy this week »

Treasury Action: Treasury…

HAL

Halliburton

09:29
01/23/17
01/23
09:29
01/23/17
09:29
Hot Stocks
Halliburton sees 2017 CapEx $1B »

Says considering various…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CFG

Citizens Financial

09:28
01/23/17
01/23
09:28
01/23/17
09:28
Upgrade
Citizens Financial rating change  »

Citizens Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STI

SunTrust

09:28
01/23/17
01/23
09:28
01/23/17
09:28
Upgrade
SunTrust rating change  »

SunTrust upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMTX

SMTC Corp.

09:27
01/23/17
01/23
09:27
01/23/17
09:27
Hot Stocks
SMTC Corp. CEO Sushil Dhiman resigns effective February 17 »

SMTC Corporation CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.